Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000899243-21-039303

Options or other derivatives

  • Director acquired 2,463 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ros Matthew · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-10-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +2,463 $5.03 $12,393 2,463 D
Loading xslF345X03/doc4.xml…